Philadelphia University + Thomas Jefferson University

Delgado, David

< Back


David Delgado, PhD

David Delgado, PhD

Contact Dr. Delgado

901 Walnut Street
10th Floor
Philadelphia, PA 19107

(215) 503-0174
(215) 923-7583 fax

Medical School

PhD - UCLA School of Public Health, Los Angeles, CA - 1994
MPH - Columbia University, Mailman School of Public Health, New York, NY - 1987
BA - Harvard University, Cambridge, MA - 1985

University Appointment

Associate Professor, Jefferson College of Population Health, 2015

Research and Clinical Interests

Dr. Delgado’s research interests are focused on patterns of care, complications, and charges associated with NHL and ulcerative colitis. Dr. Delgado also has research interests in risk factors associated with uncontrolled diabetes and asthma.


David Delgado, PhD is Director of the PhD Program in Population Health Sciences, Jefferson School of Population Health.  His primary areas of expertise include undergraduate, graduate and doctoral education, and outcomes research in oncology.  He has worked in doctoral education since 2013 and previously taught clinical epidemiology and health care finance at Villanova College of Nursing.  Dr. Delgado taught undergraduate and graduate courses at West Chester University (Associate Professor, Department of Health) and performed outcomes research at Amgen, Inc. (Senior Manager, Global Health Economics and Outcomes Research).  A major focus of his research and publication has been non-Hodgkin’s lymphoma.  Dr. Delgado has mentored undergraduate and graduate students.

Dr. Delgado earned his B.A. from Harvard University, and received his MPH in health administration and planning from Columbia University Mailman School of Public Health.  He went onto earn his PhD in health services and epidemiology from UCLA School of Public health, where he focused on breast cancer survival rates as they relate to race/ethnicity and poverty.  Dr. Delgado has over 15 years of health research experience, including the eight years and oncology outcomes research. He has worked in the Global Health Economics and Outcomes Research group at Amgen, and consulted with other pharmaceutical companies.  He has more than 10 publications across a variety of diseases in oncology.  Within the area of HEOR, Dr. Delgado’s research interests are focused on patterns of care, complications, and charges associated with NHL and ulcerative colitis.  Dr. Delgado's current research interests focus on identifying risk factors associated with diagnosis, treatment and survival disparities in pancreatic, breast (<age 40), colorectal and thyroid cancers.


Publications for this author are currently unavailable.